ZINC SULFATE= TABLETS USP 20 mg■ i

ZINC SULFATE
= TABLETS USP 20 mg
■ i ■ Composition:
Each uncaated aispersicle (ablet contains ZincSulfateUSPIas moiohydrate)54 83 mg equivalent to elemental Zinc 20 mg
Indications: Adjunct lo oral rehydration therapy in acute diarrhoea
Dose: Ad|unct lo oral rehydration therapy in acute diarrhoea Oral'
Infanl under 6months ID mg (elementalzinc)daily for 10-14 days Infant or Child over 6 months 20 mg (elemental zinc) daily Tor 10—14 days
Notes: Zinc sulfate tablets may be dispersed in breast milk, in oral rehydration solution or in water on a small spoon; older children may chew 1 abi ets or swal low the m with water Administer with food it gastrointestinal upsetoccurs
Directions (or use: Place Ihe tablet in a small spoon- Add a little woler or hreast milk- Leave the tablet to dissolve laround 45 seconds)- Give the enlire contents of the spoon to Ihe child II the child should vomit in the 30 mjnules following Ihe treatment, give another tablet (or half a table I lor the infants between 2 and6 months old)
Precautions: Acute Jena) failure (may accumulate)
Renal Impairment: May accumulate in acute renal failure
Hepatic Impairment. Dose reduction not necessary
Adverse effects: Uncommon Abdominal pain, dyspepsia, nausea, vomiting, diarrhoea gastnc irritation, gastritis, irritability, headache, lethargy
Drug Interactions:
Calcium salts: reduced absorption of zinc sulfate-Ciprofloxacin: reduced absorption of ciprofloxacin
Fe rro u s sa Its: absorption of zinc an d of oral ferrou s sal ts reduced
Ofloxacin reduced absorption ofofToxAcm
Penicillamine'absorption of both drugs reduced
Contraindications: Do not use Zinc sulphate tablets 20 mg if there is an allergy (hypersensitivity) to one of ihe components in the product, especially the zinc.
Do not use Zinc sulphate tablets 20 rig in cases of phenylketonuria (hereditary melabolic disorder identiied at birth), because of the presence of aspartame
If the child is being given iron in the same period, it is recommended that a four-hour gap be left between the tws treatments, to ensure that the organism gets the full benefit of both products.
Source:
■ WHO model formulary foi children, section 17 gastro'itestinat medicines, 17.5.2 Medicines for diarrhoea in children 2010:372.
• Clinical management of acute diarrhoea Geneva. World Health Organizadon, 2004 (http-Z/wnw who mUchild-adolescenl-health/Ne w_Publica tion&CHILO^_HEM_TH/Acute_Diarrhoea .gdf).
■ Dianhoea traatment guidelines including new recommend&tions tor the use of ORS and zinc supplementation tor clinic-basedhealthcare ivortiers. Gensva, World Health Organizaliori, 2005 (available from http'/fww* wf>o ml/c/trlci-sJo/escenl-fieaftri/ We* _Pu()(icdtions/Cff/l-D_He^i7H/Oiarr«oea_9uii(e/r"nes .pdf)
• Hill SR. Kouimtzi M. Stuart MC, eds. WHO model formulary. Geneva, WoddHealth Organization. 200H
' Nodding JH, Kreus DM. TakstomoCK. Pediatric dosage handbook 16thed.Hudson Lexi-Comp. 2009.
STORAGE:
Do not slore above SOX, protected from light
Presentation:
10x10 tablets.
ALKEM
ALKEM LABORATORIES LTD.
Alkero House, Senapati Bapat Marg. Lower Pare I, Mumbai-400 013

Результаты (русский) 3:

проблемы должны как образецЯ позиции структуры, является компания после обычных часов работы, пожалуйста, скажи мне, когда достижения цели компании ".